SCHEMBL217929

SCHEMBL217929

Oc1ccc(-c2ccc(OC3CCCCO3)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TNK2 Q07912 3/20 0.43
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
HSD11B1 P28845 1/20 0.40
ESR2 Q92731 2/20 0.39
PTPN1 P18031 1/20 0.38
DHFR P00374 1/20 0.36
ACP1 P24666 1/20 0.36
ESR1 P03372 1/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
ALDH1A1 P00352 1/20 0.35
KDM4C Q9H3R0 1/20 0.34
ALDH2 P05091 1/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL222919 0.95 MEN1 (0.43) TNK2MEN1KMT2AHSD11B1ESR2
SCHEMBL15093765 0.95 MEN1 (0.43) TNK2MEN1KMT2AHSD11B1ESR2
SCHEMBL15093959 0.95 MEN1 (0.43) TNK2MEN1KMT2AHSD11B1ESR2
SCHEMBL15214980 0.90 ALDH1A1 (0.41) TNK2MEN1KMT2AHSD11B1ESR2
SCHEMBL15214979 0.90 ALDH1A1 (0.41) TNK2MEN1KMT2AHSD11B1ESR2
SCHEMBL7155013 0.90 ALDH1A1 (0.41) TNK2MEN1KMT2AHSD11B1ESR2
SCHEMBL17754258 0.89 ESR1 (0.44) TNK2MEN1KMT2AHSD11B1ESR2
SCHEMBL7785436 0.88 NPC1 (0.50) TNK2MEN1KMT2AHSD11B1ESR2
SCHEMBL16055037 0.88 HSD11B1 (0.41) TNK2MEN1KMT2AHSD11B1PTPN1
SCHEMBL14564207 0.87 TNK2 (0.37) TNK2MEN1KMT2AACP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113493690-B Compound, liquid crystal composition and liquid crystal display element 石家庄诚志永华显示材料有限公司 2025-01-17 CN disclosed
CN-113493690-A Compound, liquid crystal composition and liquid crystal display element DIC株式会社 2021-10-12 CN disclosed
US-20190144750-A1 POLYMERIZABLE COMPOUND AND LIQUID CRYSTAL COMPOSITION CONTAINING THE SAME DIC CORPORATION (JP) 2019-05-16 US disclosed
US-20160137921-A1 POLYMERIZABLE COMPOUND, AND LIQUID CRYSTAL COMPOSITION PRODUCED USING SAME DIC CORPORATION (JP) 2016-05-19 US disclosed
US-20160137921-A1 POLYMERIZABLE COMPOUND, AND LIQUID CRYSTAL COMPOSITION PRODUCED USING SAME DIC CORPORATION (JP) 2016-05-19 US disclosed
US-8089584-B2 Liquid crystal display panel and method for fabricating the same AU OPTRONICS CORP. (TW) 2012-01-03 US disclosed
US-8089584-B2 Liquid crystal display panel and method for fabricating the same AU OPTRONICS CORP. (TW) 2012-01-03 US disclosed
US-8089584-B2 Liquid crystal display panel and method for fabricating the same AU OPTRONICS CORP. (TW) 2012-01-03 US disclosed
US-20100238382-A1 LIQUID CRYSTAL DISPLAY PANEL AND METHOD FOR FABRICATING THE SAME AU OPTRONICS CORP. (TW) 2010-09-23 US disclosed
US-20100238382-A1 LIQUID CRYSTAL DISPLAY PANEL AND METHOD FOR FABRICATING THE SAME AU OPTRONICS CORP. (TW) 2010-09-23 US disclosed
US-20100238382-A1 LIQUID CRYSTAL DISPLAY PANEL AND METHOD FOR FABRICATING THE SAME AU OPTRONICS CORP. (TW) 2010-09-23 US disclosed
EP-0830440-A1 LIQUID-CRYSTALLINE POLYMER MATERIAL Lagerwall, Sven Yngve Torbjörn (SE) 1998-03-25 EP disclosed
WO-1996024648-A1 LIQUID-CRYSTALLINE POLYMER MATERIAL LAGERWALL SVEN TORBJOERN (SE) 1996-08-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160137921-A1 POLYMERIZABLE COMPOUND, AND LIQUID CRYSTAL COMPOSITION PRODUCED USING SAME RCC1, LPXN, SMC4 TNK2 849/4885MEN1 1517/4885KMT2A 2308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.